Inr goals chart
1.2. Alternative INR goals may be chosen for specific patients when bleeding risk outweighs clotting risk and will be determined by the individual’s provider (Class IIb, Level C) Table 1. Indications for Antithrombotics, INR Ranges, and Duration of Therapy2-10 Indication INR (Range) Duration Comments Thrombophilia with Thromboembolic Event2 The international normalized ratio (INR) recommendations below are per guidelines from the American College of Chest Physicians (2008). Rheumatic mitral valve disease INR target (range) Atrial fibrillation (AF), prior embolism, and/or left atrial thrombus: 2. INR goals and duration of therapy listed in Table 1 are recommended by the CHEST guidelines.2,4-8 (Class I, Level B) University of Wisconsin – UW Health 1.1. Exceptions include orthopedic surgery INR goals which are recommendations provided Recommended Therapeutic Range and Duration of Warfarin Therapy Diagnosis Target INR Duration Deep Vein Thrombosis (transient risk - 1st episode) (idiopathic – 1st episode) (recurrent VTE) (associated active malignancy) 2.0-3.0 3 months At least 6-12 months* Indefinite Until remission Pulmonary Embolism (transient risk - 1st episode)
Setting a narrow international normalized ratio (INR) target range might potentially mitigate some of these Results: Data of 150 patients with a narrow INR target range (2.0- fibrillation: Detailed chart review essential to capture contraindi-.
INR likely to exit target range (e.g. new interacting drugs). • Dose adjustments The following chart should be used to select the correct dose and syringe size:. Adjusted-dose warfarin therapy alone – INR range of 2.0 to 3.0 (target INR of 2.5) rather than the combination of adjusted-dose warfarin therapy and aspirin (Grade 2C) Mechanical mitral valve: INR target of 3.0 (range, 2.5-3.5) (Grade 2C) Goal Range: 2.0 - 3.0. Keeping track of your blood test results helps you and your doctor see whether your medicine is helping you to stay within, above, or below your goal range. Use this chart to keep a record of your results. This chart illustrates typical therapeutic INR levels, while using Coumadin (warfarin) therapy. An INR up to 10 is targeted in hyper-therapeutic situations, where any clotting at all absolutely must be avoided. For Goal INR 2-3 Dosing Adjustments: For Goal INR 2.5-3.5 INR < 1.5: consider a booster dose of 1 ½ -2 times daily maintenance dose; consider resumption of prior maintenance dose if factor causing decreased INR is transient [eg: missed warfarin dose(s)]
The goal of urgent warfarin reversal, therefore, is to increase the available amount of Vitamin–K dependent clotting factors which will lead to a decrease in INR.
2 Oct 2018 Anticoagulation, Prescription Chart, Warfarin prescription, Warfarin. Target Target INR of 3.0 leads to fewer cancellations of the procedure.
INR likely to exit target range (e.g. new interacting drugs). • Dose adjustments The following chart should be used to select the correct dose and syringe size:.
Warfarin Initiation Nomogram (10mg starting dose, INR target range 2-3)2. This algorithm Other pertinent information found during chart review. Information v Concurrent use of anticoagulants (e.g. warfarin with INR >2.0) □ v Lumbar anticoagulation effect Target INR of <1.5 at time of catheter Prescription Chart.
Goal Range: 2.0 - 3.0. Keeping track of your blood test results helps you and your doctor see whether your medicine is helping you to stay within, above, or below your goal range. Use this chart to keep a record of your results.
The patient flow chart is shown in figure 1. The target INR window is 1.8–2.5 ( 1.8–2.2 for aortic valve replacement, 2.0–2.5 for mitral valve replacement and 11 Jul 2011 The International Normalized Ratio (INR) is the recommended method for monitoring warfarin, and the target goal is set by the provider, based on
See Appendix 3, Recommended INR Target and Duration of Warfarin Therapy Appendix 6 for a chart showing the recommended frequency of clinic visits for Anticoagulation Services consult. II. WARFARIN ANTICOAGULATION. Indication. Target INR Range. •. Prophylaxis of venous thrombosis (high-risk patients).